{"id":"W4402022435","doi":"10.1016/j.ahj.2024.08.011","title":"Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design","year":2024,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"Janssen Research and Development; Bristol-Myers Squibb","keywords":"Medicine; Apixaban; Atrial fibrillation; Stroke (engine); Atrial flutter; Cardiology; Internal medicine; Limiting; Major bleeding; Dabigatran; Oral anticoagulant; Rivaroxaban; Warfarin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004099394,0.001842033,0.00284951,0.0005016864,0.0006258251,0.001930798,0.00115507,0.002127882,0.01186626],"category_scores_gemma":[0.004849094,0.0006950374,0.001714694,0.000713594,0.001129717,0.001722206,0.000792663,0.003001806,0.001899971],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006283571,"about_ca_system_score_gemma":0.001503333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004801043,"about_ca_topic_score_gemma":0.000989026,"domain_scores_codex":[0.9979414,0.001179381,0.000155157,0.000296193,0.0002014771,0.0002263635],"domain_scores_gemma":[0.9990298,0.0002983177,0.0001698152,0.00009555844,0.00009334225,0.0003132306],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.9355521,0.00473562,0.003545649,0.00581231,0.002991111,0.0002268809,0.0001671528,0.001125075,0.001845918,0.003395098,0.01103711,0.02956597],"study_design_scores_gemma":[0.9375525,0.03072157,0.005324,0.0008488949,0.003570271,0.0001882317,0.0001105718,0.001697033,0.0005936528,0.004179141,0.01514517,0.00006910045],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.5533799,0.06385413,0.007825067,0.01331911,0.004896664,0.2725001,0.02006306,0.0007180661,0.063444],"genre_scores_gemma":[0.6640516,0.01363506,0.01143665,0.01239924,0.003085836,0.2691364,0.01022437,0.0001016928,0.01592909],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.01186626,"threshold_uncertainty_score":0.03969663,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08702958010064202,"score_gpt":0.3703784012846614,"score_spread":0.2833488211840194,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}